-
Je něco špatně v tomto záznamu ?
Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer
D. Cibula, D. Kužel, J. Sláma, D. Fischerová, P. Dundr, P. Freitag, M. Zikán, D. Pavlišta, V. Tomancová
Jazyk angličtina Země Spojené státy americké
Typ dokumentu financování organizované
Grantová podpora
NS10037
MZ0
CEP - Centrální evidence projektů
- MeSH
- barvicí látky diagnostické užití MeSH
- biopsie sentinelové lymfatické uzliny metody normy MeSH
- dospělí MeSH
- falešně pozitivní reakce MeSH
- financování organizované MeSH
- laparoskopie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymfadenektomie MeSH
- lymfatické uzliny chirurgie patologie MeSH
- mladý dospělý MeSH
- nádory děložního čípku chirurgie patologie MeSH
- rosanilinová barviva diagnostické užití MeSH
- senioři MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- senioři MeSH
- ženské pohlaví MeSH
OBJECTIVES: Sentinel lymph node (SLN) biopsy can significantly contribute to the management of locally advanced cervical cancers with high risk of lymph node (LN) positivity. However, low detection rate and sensitivity were reported in larger tumors, albeit on a small number of cases. It was the aim of our study to verify the SLN reliability in large tumors, with modified dye application technique and a careful identification of side-specific lymphatic drainage. METHODS: The study involved 44 patients with tumors 3 cm in diameter or larger, stages IB1 to IIA, or selected IIB. In cases where SLN could not be detected, systematic pelvic lymphadenectomy was performed on the respective side. Systematic pelvic lymphadenectomy was performed during the second step radical procedure if not already done. RESULTS: Detection rate in the whole cohort reached 77% per patient and 59% bilaterally. No significant difference was found whether a blue dye or a combined method was used (75% vs 80%, and 55% vs 67%). Systematic pelvic lymphadenectomy was performed in cases with undetected SLN unilaterally in 8 and bilaterally in 10 women. A systematic pelvic lymphadenectomy was included in the second step radical procedure in 19 cases and no positive LN were found. There was no case of false-negative SLN result in patients who underwent surgical treatment. CONCLUSION: Detection rate in locally advanced cervical cancer could be improved by a careful dye application technique. Low false-negative SLN rate could be achieved if pelvic lymphatic drainage is evaluated on a side-specific principle by performing systematic lymphadenectomy if SLN is not detected.
Citace poskytuje Crossref.org
- 000
- 03571naa 2200517 a 4500
- 001
- bmc11019483
- 003
- CZ-PrNML
- 005
- 20140328110058.0
- 008
- 110714s2009 xxu e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.ygyno.2009.06.017 $2 doi
- 035 __
- $a (PubMed)19646741
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cibula, David, $d 1968- $7 jo20000074072
- 245 10
- $a Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer / $c D. Cibula, D. Kužel, J. Sláma, D. Fischerová, P. Dundr, P. Freitag, M. Zikán, D. Pavlišta, V. Tomancová
- 314 __
- $a Department of Obstetrics and Gynecology, General Teaching Hospital in Prague, First Medical School, Charles University, Oncogynecological Center, Prague 2, Czech Republic. david.cibula@iol.cz
- 520 9_
- $a OBJECTIVES: Sentinel lymph node (SLN) biopsy can significantly contribute to the management of locally advanced cervical cancers with high risk of lymph node (LN) positivity. However, low detection rate and sensitivity were reported in larger tumors, albeit on a small number of cases. It was the aim of our study to verify the SLN reliability in large tumors, with modified dye application technique and a careful identification of side-specific lymphatic drainage. METHODS: The study involved 44 patients with tumors 3 cm in diameter or larger, stages IB1 to IIA, or selected IIB. In cases where SLN could not be detected, systematic pelvic lymphadenectomy was performed on the respective side. Systematic pelvic lymphadenectomy was performed during the second step radical procedure if not already done. RESULTS: Detection rate in the whole cohort reached 77% per patient and 59% bilaterally. No significant difference was found whether a blue dye or a combined method was used (75% vs 80%, and 55% vs 67%). Systematic pelvic lymphadenectomy was performed in cases with undetected SLN unilaterally in 8 and bilaterally in 10 women. A systematic pelvic lymphadenectomy was included in the second step radical procedure in 19 cases and no positive LN were found. There was no case of false-negative SLN result in patients who underwent surgical treatment. CONCLUSION: Detection rate in locally advanced cervical cancer could be improved by a careful dye application technique. Low false-negative SLN rate could be achieved if pelvic lymphatic drainage is evaluated on a side-specific principle by performing systematic lymphadenectomy if SLN is not detected.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a barvicí látky $x diagnostické užití $7 D004396
- 650 _2
- $a falešně pozitivní reakce $7 D005189
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laparoskopie $7 D010535
- 650 _2
- $a lymfadenektomie $7 D008197
- 650 _2
- $a lymfatické uzliny $x chirurgie $x patologie $7 D008198
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a rosanilinová barviva $x diagnostické užití $7 D012394
- 650 _2
- $a biopsie sentinelové lymfatické uzliny $x metody $x normy $7 D021701
- 650 _2
- $a nádory děložního čípku $x chirurgie $x patologie $7 D002583
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Kužel, David, $d 1954- $7 nlk19990073454
- 700 1_
- $a Sláma, Jiří $7 xx0105772
- 700 1_
- $a Fischerová, Daniela $7 xx0074804
- 700 1_
- $a Dundr, Pavel $7 xx0080436
- 700 1_
- $a Freitag, Pavel, $d 1951- $7 xx0018148
- 700 1_
- $a Zikán, Michal, $d 1976- $7 xx0096708
- 700 1_
- $a Pavlišta, David $7 xx0057882
- 700 1_
- $a Tomancová, Věra $7 xx0123263
- 773 0_
- $t Gynecologic Oncology $w MED00001958 $g Roč. 115, č. 1 (2009), s. 46-50
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110715095048 $b ABA008
- 991 __
- $a 20140328110133 $b ABA008
- 999 __
- $a ok $b bmc $g 864445 $s 729358
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00001958 $b 115 $c 1 $d 46-50 $m Gynecologic oncology $n Gynecol Oncol
- GRA __
- $a NS10037 $p MZ0
- LZP __
- $a 2011-3B09/Bjvme